We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.53%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$64.8B
AUM Growth
-$1.23B
(-1.9%)
Cap. Flow
+$395M
Cap. Flow
% of AUM
0.61%
Top 10 Holdings %
Top 10 Hldgs %
28.4%
Holding
1,116
New
212
Increased
277
Reduced
389
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$330M |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$214M |
| 3 |
Boston Scientific
BSX
|
+$204M |
| 4 |
RB Global
RBA
|
+$183M |
| 5 |
Chevron
CVX
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RNAM
Avidity Biosciences
RNAM
|
+$190M |
| 2 |
Royalty Pharma
RPRX
|
+$187M |
| 3 |
Dover
DOV
|
+$178M |
| 4 |
Boeing
BA
|
+$168M |
| 5 |
Devon Energy
DVN
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.24% |
| 2 | Healthcare | 15.45% |
| 3 | Financials | 12.46% |
| 4 | Industrials | 9.23% |
| 5 | Communication Services | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Southwest Airlines
LUV
$22.1B
| $18.2M | 0.03% |
483,377
+16,500
| +4% | +$745K |
|
502
Dyne Therapeutics
DYN
$4.04B
| $18.1M | 0.03% |
1,000,000
-4,172,000
| -81% | -$71.9M |
|
503
UMB Financial
UMBF
$10.7B
| $18.1M | 0.03% |
160,691
-219,520
| -58% | -$26.4M |
|
|
OTGA
504
OTG Acquisition Corp I
OTGA
$300M
| $18.1M | 0.03% |
1,800,000
| – | – |
|
505
NetApp
NTAP
$32.9B
| $18.1M | 0.03% |
176,700
+21,500
| +14% | +$2.18M |
|
|
HVMC
506
Highview Merger Corp
HVMC
$300M
| $18.1M | 0.03% |
1,800,000
| – | – |
|
507
CF Industries
CF
$19.2B
| $18.1M | 0.03% |
139,122
-161,700
| -54% | -$16.5M |
|
|
TMTSU
508
Spartacus Acquisition Corp II Unit
TMTSU
| $18.1M | 0.03% |
+1,800,000
| New | +$18.1M |
|
|
KPET.U
509
KPET Ultra Paceline Corp Units
KPET.U
| $18M | 0.03% |
+1,800,000
| New | +$18M |
|
510
Booz Allen Hamilton
BAH
$8.7B
| $18M | 0.03% |
230,200
+155,318
| +207% | +$13.1M |
|
511
SouthState Bank Corp
SSB
$10.3B
| $17.9M | 0.03% |
193,800
-30,000
| -13% | -$2.94M |
|
|
SAC
512
Safeguard Acquisition Corp
SAC
| $17.9M | 0.03% |
+1,800,000
| New | +$18M |
|
|
CAQUU
513
Cambridge Acquisition Corp
CAQUU
$205M
| $17.9M | 0.03% |
+1,800,000
| New | +$17.9M |
|
|
SAAQ
514
Space Asset Acquisition Corp
SAAQ
$319M
| $17.9M | 0.03% |
+1,800,000
| New | +$17.9M |
|
515
Saia
SAIA
$11.3B
| $17.9M | 0.03% |
+51,000
| New | +$18.6M |
|
|
TRGSU
516
TRG Latin America Acquisitions Corp Units
TRGSU
| $17.9M | 0.03% |
+1,800,000
| New | +$18M |
|
|
AACOU
517
Abony Acquisition Corp I Units
AACOU
| $17.9M | 0.03% |
+1,800,000
| New | +$17.9M |
|
|
VACI
518
Viking Acquisition Corp I
VACI
$311M
| $17.9M | 0.03% |
1,800,000
| – | – |
|
519
Kroger
KR
$34.8B
| $17.8M | 0.03% |
246,600
-192,800
| -44% | -$13M |
|
|
GPAC
520
General Purpose Acquisition Corp
GPAC
| $17.8M | 0.03% |
+1,800,000
| New | +$17.8M |
|
|
DSAC
521
Daedalus Special Acquisition Corp
DSAC
$346M
| $17.8M | 0.03% |
+1,800,000
| New | +$17.9M |
|
|
LEGO
522
Legato Merger Corp IV
LEGO
$312M
| $17.8M | 0.03% |
+1,800,000
| New | +$17.8M |
|
523
Raymond James Financial
RJF
$32.5B
| $17.8M | 0.03% |
123,150
+11,000
| +10% | +$1.74M |
|
|
FGII
524
FG Imperii Acquisition Corp
FGII
$288M
| $17.8M | 0.03% |
+1,800,000
| New | +$17.8M |
|
|
AEAQ
525
Activate Energy Acquisition Corp
AEAQ
| $17.8M | 0.03% |
+1,800,000
| New | +$17.8M |
|
Similar funds
Adage Capital Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Adage Capital Partners held 1,116 positions worth $64.8B, down 1.9% from $66.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Adage Capital Partners's Q1 2026 filing shows 212 new, 277 increased, 389 reduced and 160 closed positions. Its largest new stake was Takeda Pharmaceutical: 6,424,984 shares worth $119M. The largest sale was Avidity Biosciences, an estimated $190M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q1 2026 buy was Takeda Pharmaceutical: 6,424,984 shares worth $119M.
- Adage Capital Partners added most to Revolution Medicines in Q1 2026, an estimated $330M increase.
- Adage Capital Partners's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $187M.
- Adage Capital Partners fully exited Avidity Biosciences in Q1 2026, selling an estimated $190M.
- Adage Capital Partners's ten largest holdings make up 28% of its $64.8B portfolio in Q1 2026.
- Adage Capital Partners opened 212 new positions and closed 160 in Q1 2026.
- Adage Capital Partners's portfolio value fell 1.9% quarter-over-quarter to $64.8B.
Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.